UNITY Biotechnology has appointed Federico Grossi, M.D., Ph.D., as its new chief medical officer to enhance its leadership team. Dr. Grossi, who has over 20 years of experience in biotech, previously ...
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UBX) (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, ...
Quirino’s signature service-on-wheels is back on the road—stronger, wider in scope, and more community-centred than ever. The I Love Quirino Caravan has officially resumed its 8th leg, bringing ...
– Renowned Scientist and Drug Developer Joins UNITY’s Mission to Extend Healthspan – – Succeeds Keith Leonard Who Will Continue as Chairman – SAN FRANCISCO, March 02, 2020 (GLOBE NEWSWIRE) -- UNITY ...
“Dr. Grossi’s extensive experience in clinical strategy and a successful track record of advancing novel ophthalmology programs from inception through approval and commercial launch make him an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback